Literature DB >> 27532820

Comprehensive Protocols for CRISPR/Cas9-based Gene Editing in Human Pluripotent Stem Cells.

David P Santos1, Evangelos Kiskinis1, Kevin Eggan2,3, Florian T Merkle4.   

Abstract

Genome editing of human pluripotent stem cells (hPSCs) with the CRISPR/Cas9 system has the potential to revolutionize hPSC-based disease modeling, drug screening, and transplantation therapy. Here, we aim to provide a single resource to enable groups, even those with limited experience with hPSC culture or the CRISPR/Cas9 system, to successfully perform genome editing. The methods are presented in detail and are supported by a theoretical framework to allow for the incorporation of inevitable improvements in the rapidly evolving gene-editing field. We describe protocols to generate hPSC lines with gene-specific knock-outs, small targeted mutations, or knock-in reporters. © 2016 by John Wiley & Sons, Inc.
Copyright © 2016 John Wiley & Sons, Inc.

Entities:  

Keywords:  CRISPR; gene editing; knock-in; pluripotent; stem cell

Mesh:

Substances:

Year:  2016        PMID: 27532820      PMCID: PMC4988528          DOI: 10.1002/cpsc.15

Source DB:  PubMed          Journal:  Curr Protoc Stem Cell Biol        ISSN: 1938-8969


  102 in total

1.  Enrichment and efficient screening of ES cells containing a targeted mutation: the use of DT-A gene with the polyadenylation signal as a negative selection maker.

Authors:  Y Yanagawa; T Kobayashi; M Ohnishi; T Kobayashi; S Tamura; T Tsuzuki; M Sanbo; T Yagi; F Tashiro; J Miyazaki
Journal:  Transgenic Res       Date:  1999-06       Impact factor: 2.788

Review 2.  DNA double-strand break repair.

Authors:  C Featherstone; S P Jackson
Journal:  Curr Biol       Date:  1999-10-21       Impact factor: 10.834

3.  Mutation detection using Surveyor nuclease.

Authors:  Peter Qiu; Harini Shandilya; James M D'Alessio; Kevin O'Connor; Jeffrey Durocher; Gary F Gerard
Journal:  Biotechniques       Date:  2004-04       Impact factor: 1.993

4.  Southern blotting.

Authors:  Ed Southern
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

5.  Genomic sequence correction by single-stranded DNA oligonucleotides: role of DNA synthesis and chemical modifications of the oligonucleotide ends.

Authors:  Petter Angell Olsen; Markus Randøl; Luisa Luna; Tom Brown; Stefan Krauss
Journal:  J Gene Med       Date:  2005-12       Impact factor: 4.565

6.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

Review 7.  Culture and characterization of human embryonic stem cells.

Authors:  Jonathan S Draper; Harry D Moore; Ludmila N Ruban; Paul J Gokhale; Peter W Andrews
Journal:  Stem Cells Dev       Date:  2004-08       Impact factor: 3.272

8.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

9.  Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations.

Authors:  Jan Pruszak; Kai-Christian Sonntag; Moe Hein Aung; Rosario Sanchez-Pernaute; Ole Isacson
Journal:  Stem Cells       Date:  2007-06-21       Impact factor: 6.277

10.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

View more
  9 in total

1.  Modeling Pediatric Epilepsy Through iPSC-Based Technologies.

Authors:  Dina Simkin; Evangelos Kiskinis
Journal:  Epilepsy Curr       Date:  2018 Jul-Aug       Impact factor: 7.500

2.  CRISPR/Cas9-based Targeted Genome Editing for the Development of Monogenic Diseases Models with Human Pluripotent Stem Cells.

Authors:  Navin Gupta; Koichiro Susa; Yoko Yoda; Joseph V Bonventre; M Todd Valerius; Ryuji Morizane
Journal:  Curr Protoc Stem Cell Biol       Date:  2018-04-26

Review 3.  Editing the genome of hiPSC with CRISPR/Cas9: disease models.

Authors:  Andrew R Bassett
Journal:  Mamm Genome       Date:  2017-03-16       Impact factor: 2.957

Review 4.  Developments in cell culture systems for human pluripotent stem cells.

Authors:  Weiwei Liu; Chunhao Deng; Carlos Godoy-Parejo; Yumeng Zhang; Guokai Chen
Journal:  World J Stem Cells       Date:  2019-11-26       Impact factor: 5.326

5.  Cardiac cell type-specific gene regulatory programs and disease risk association.

Authors:  James D Hocker; Olivier B Poirion; Fugui Zhu; Justin Buchanan; Kai Zhang; Joshua Chiou; Tsui-Min Wang; Qingquan Zhang; Xiaomeng Hou; Yang E Li; Yanxiao Zhang; Elie N Farah; Allen Wang; Andrew D McCulloch; Kyle J Gaulton; Bing Ren; Neil C Chi; Sebastian Preissl
Journal:  Sci Adv       Date:  2021-05-14       Impact factor: 14.136

Review 6.  Concise Review: Stem Cell Models of SCN1A-Related Encephalopathies-Current Perspective and Future Therapies.

Authors:  Valery Zayat; Roza Szlendak; Dorota Hoffman-Zacharska
Journal:  Cells       Date:  2022-10-04       Impact factor: 7.666

7.  A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease.

Authors:  Dane Z Hazelbaker; Amanda Beccard; Anne M Bara; Nicole Dabkowski; Angelica Messana; Patrizia Mazzucato; Daisy Lam; Danielle Manning; Kevin Eggan; Lindy E Barrett
Journal:  Stem Cell Reports       Date:  2017-10-10       Impact factor: 7.765

Review 8.  Inherited cardiac diseases, pluripotent stem cells, and genome editing combined-the past, present, and future.

Authors:  Lettine van den Brink; Catarina Grandela; Christine L Mummery; Richard P Davis
Journal:  Stem Cells       Date:  2019-12-16       Impact factor: 6.277

9.  Homozygous might be hemizygous: CRISPR/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls.

Authors:  Dina Simkin; Vasileios Papakis; Bernabe I Bustos; Christina M Ambrosi; Steven J Ryan; Valeriya Baru; Luis A Williams; Graham T Dempsey; Owen B McManus; John E Landers; Steven J Lubbe; Alfred L George; Evangelos Kiskinis
Journal:  Stem Cell Reports       Date:  2022-03-10       Impact factor: 7.294

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.